Esperion Therapeutics
Price & Volume
Stats
See more52W Range | $0.69-$3.94 |
Market Cap | $534.3M |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $268.1M |
Revenue Growth (YoY) | 11.6% |
Gross Profit (12 Mos) | $123.9M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 5 days ago
Oritain expands traceability offer to leather
Yahoo Finance • 10 days ago
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia
Yahoo Finance • last month
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
Yahoo Finance • 2 months ago
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
About
CEO | Mr. Sheldon L. Koenig |
Address | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 304 |
